Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Epirubicin × Clear all

Phase

Phase 1/2 2 Phase 1 2 Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 66 Stomach Neoplasms 8 Triple Negative Breast Neoplasms 7 Carcinoma, Hepatocellular 6 Inflammatory Breast Neoplasms 5 Non-Muscle Invasive Bladder Neoplasms 3 Primary Breast Cancer 2 Pathologic Complete Response 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Ductal, Breast 2 Urinary Bladder Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Resectable HER2-positive Breast Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 HER2 Positive Early Breast Cancer 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Epstein-Barr Virus Infections 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00798070 2024-12-18

PANTHER

Karolinska University Hospital

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡